Big Moving Stocks for Nov-11 At The Close
These stocks are posting some big moves for today.
Digital Ally Inc. (DGLY) < (DGLY) is currently trading at $7.55 + 1.65 (27.97%) on 920,810 shares traded. Digital Ally Inc. (DGLY) < is -50.72% year-to-date, and -39.82% over the last 12 months.
Digital Ally Inc., is engaged in the production and sale of digital video imaging, audio recording, and related storage products for use in law enforcement, security & commercial applications in the United States and other countries.
Voyager Therapeutics Inc (VYGR) < (VYGR) is currently trading at $17.61 + 3.61 (25.79%) on 1,183,044 shares traded. Voyager Therapeutics Inc (VYGR) < is -- year-to-date, and -- over the last 12 months.
Voyager Therapeutics Inc is a clinical-stage gene therapy company. The Company is engaged in developing life-changing treatments for patients suffering from severe diseases of the central nervous system, or CNS.
Pulmatrix Inc (PULM) < (PULM) is currently trading at $4.38 + 0.677 (18.30%) on 29,039 shares traded. Pulmatrix Inc (PULM) < is -49.98% year-to-date, and -57.13% over the last 12 months.
Pulmatrix Inc is developing inhaled therapies to address serious pulmonary disease using its clinically validated, proprietary iSPERSE technology.
Global Defense & National Security System Inc (GDEF) < (GDEF) is currently trading at $12.75 + 1.87 (17.19%) on 3,307 shares traded. Global Defense & National Security System Inc (GDEF) < is +23.55% year-to-date, and +20.98% over the last 12 months.
Global Defense & National Security Systems Inc is a blank check development stage company. It is formed for the purpose of acquiring, through a merger, capital stock exchange, and asset acquisition.
Hackett Group Inc (HCKT) < (HCKT) is currently trading at $18.58 + 2.65 (16.64%) on 823,168 shares traded. Hackett Group Inc (HCKT) < is +111.38% year-to-date, and +126.21% over the last 12 months.
The Hackett Group Inc is an advisory firm. The Company provides advisory, benchmarking and transformation consulting services including shares services, offshoring and outsourcing advice.
Alarm.com Holdings Inc (ALRM) < (ALRM) is currently trading at $16.97 + 2.40 (16.47%) on 1,285,286 shares traded. Alarm.com Holdings Inc (ALRM) < is -- year-to-date, and -- over the last 12 months.
Alarm.com Holdings Inc is a cloud-based software platform solution for the connected home. The Company through its cloud-based services makes connected home technology accessible to millions of home and business owners.
Calithera Biosciences Inc. (CALA) < (CALA) is currently trading at $7.80 + 1.09 (16.16%) on 635,664 shares traded. Calithera Biosciences Inc. (CALA) < is -61.39% year-to-date, and -22.80% over the last 12 months.
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Eco-Stim Energy Solutions Inc (ESES) < (ESES) is currently trading at $4.91 + 0.60 (13.92%) on 10,783 shares traded. Eco-Stim Energy Solutions Inc (ESES) < is -24.46% year-to-date, and -6.48% over the last 12 months.
Eco-Stim Energy Solutions Inc is an early stage technology-driven independent oilfield services company. The Company is engaged in providing well stimulation, coiled tubing and field management services to the upstream oil and gas industry.
Otonomy Inc (OTIC) < (OTIC) is currently trading at $27.84 + 3.38 (13.82%) on 448,966 shares traded. Otonomy Inc (OTIC) < is -16.47% year-to-date, and +16.86% over the last 12 months.
Otonomy Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear.
Neos Therapeutics Inc (NEOS) < (NEOS) is currently trading at $14.48 + 1.65 (12.86%) on 117,104 shares traded. Neos Therapeutics Inc (NEOS) < is -- year-to-date, and -- over the last 12 months.
Neos Therapeutics Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platform.
